Manulife (Manufacturers Life Insurance)
LAB icon

Manulife (Manufacturers Life Insurance)’s Standard BioTools LAB Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75K Sell
81,553
-11,333
-12% -$13.7K ﹤0.01% 2677
2025
Q4 		$119K Sell
92,886
-13,252
-12% -$17.8K ﹤0.01% 2668
2025
Q3 		$138K Sell
106,138
-9,211
-8% -$12.1K ﹤0.01% 2700
2025
Q2 		$138K Buy
115,349
+7,570
+7% +$8.39K ﹤0.01% 2689
2025
Q1 		$116K Sell
107,779
-2,429
-2% -$3.41K ﹤0.01% 2662
2024
Q4 		$193K Sell
110,208
-4,031
-4% -$7.51K ﹤0.01% 2633
2024
Q3 		$220K Sell
114,239
-3,156
-3% -$6.18K ﹤0.01% 2624
2024
Q2 		$208K Buy
+117,395
New +$287K ﹤0.01% 2593
2022
Q2 		– Sell
-33,512
Closed -$120K – 3077
2022
Q1 		$120K Sell
33,512
-9,054
-21% -$31.3K ﹤0.01% 2928
2021
Q4 		$167 Buy
42,566
+787
+2% +$3.68K ﹤0.01% 2959
2021
Q3 		$275K Sell
41,779
-1,954
-4% -$12.9K ﹤0.01% 2740
2021
Q2 		$269K Sell
43,733
-970
-2% -$5.18K ﹤0.01% 2892
2021
Q1 		$202K Sell
44,703
-992
-2% -$5.45K ﹤0.01% 2888
2020
Q4 		$274K Buy
45,695
+3,968
+10% +$26.1K ﹤0.01% 2575
2020
Q3 		$310K Sell
41,727
-2,197
-5% -$15.2K ﹤0.01% 2274
2020
Q2 		$180K Sell
43,924
-2,516
-5% -$8.76K ﹤0.01% 2552
2020
Q1 		$118K Buy
46,440
+2,615
+6% +$8.59K ﹤0.01% 2528
2019
Q4 		$153K Buy
43,825
+690
+2% +$2.43K ﹤0.01% 2677
2019
Q3 		$203K Buy
43,135
+1,344
+3% +$10.6K ﹤0.01% 2581
2019
Q2 		$515K Buy
41,791
+30,058
+256% +$383K ﹤0.01% 2028
2019
Q1 		$156K Buy
+11,733
New +$124K ﹤0.01% 2491
2018
Q4 		– Sell
-10,725
Closed -$80K – 2691
2018
Q3 		$80K Buy
10,725
+10,233
+2,080% +$72.7K ﹤0.01% 2909
2018
Q2 		$3K Sell
492
-31,912
-98% -$182K ﹤0.01% 4160
2018
Q1 		$190K Sell
32,404
-447
-1% -$2.94K ﹤0.01% 3058
2017
Q4 		$193K Buy
32,851
+20,570
+167% +$113K ﹤0.01% 3027
2017
Q3 		$63K Buy
12,281
+11,357
+1,229% +$47.7K ﹤0.01% 3428
2017
Q2 		$4K Sell
924
-22,776
-96% -$108K ﹤0.01% 3987
2017
Q1 		$135K Buy
23,700
+2,707
+13% +$17.2K ﹤0.01% 3050
2016
Q4 		$153K Sell
20,993
-857
-4% -$5.38K ﹤0.01% 2988
2016
Q3 		$175K Sell
21,850
-388
-2% -$3.56K ﹤0.01% 2871
2016
Q2 		$201K Buy
22,238
+1,682
+8% +$15.8K ﹤0.01% 2704
2016
Q1 		$166K Buy
20,556
+868
+4% +$6.26K ﹤0.01% 2729
2015
Q4 		$213 Buy
19,688
+694
+4% +$6.82K ﹤0.01% 2617
2015
Q3 		$155 Buy
18,994
+428
+2% +$6.74K ﹤0.01% 2856
2015
Q2 		$449 Buy
18,566
+44
+0.2% +$1.39K ﹤0.01% 2200
2015
Q1 		$779 Buy
18,522
+558
+3% +$22.1K ﹤0.01% 1813
2014
Q4 		$606 Sell
17,964
-408
-2% -$11.6K ﹤0.01% 1873
2014
Q3 		$450 Buy
18,372
+485
+3% +$13.6K ﹤0.01% 2054
2014
Q2 		$526K Sell
17,887
-1,302
-7% -$41.7K ﹤0.01% 2013
2014
Q1 		$845 Sell
19,189
-303
-2% -$13.3K ﹤0.01% 1744
2013
Q4 		$747 Sell
19,492
-1,964
-9% -$57.8K ﹤0.01% 1795
2013
Q3 		$471 Buy
21,456
+118
+0.6% +$2.32K ﹤0.01% 2032
2013
Q2 		$373K Buy
+21,338
New +$374K ﹤0.01% 2079

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s LAB Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Standard BioTools (LAB) stake by 12% in Q1 2026, selling an estimated $13.7K and leaving 81,553 shares worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #2677.

Manulife (Manufacturers Life Insurance) first reported a position in LAB in Q2 2013 and has held it in 43 quarters since. The position peaked at $526K in Q2 2014. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 81,553 shares of Standard BioTools worth $75K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 11,333 Standard BioTools shares in Q1 2026, an estimated $13.7K.
  • Standard BioTools made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2677 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Standard BioTools in Q2 2013 and has held it in 43 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Standard BioTools position peaked at $526K in Q2 2014.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.